Genetically determined serum urate levels and cardiovascular and other diseases in UK Biobank cohort: A phenome-wide mendelian randomization study

Published on Oct 18, 2019in PLOS Medicine
· DOI :10.1371/journal.pmed.1002937
Xue Li8
Estimated H-index: 8
(Edin.: University of Edinburgh),
Xiangrui Meng5
Estimated H-index: 5
(Edin.: University of Edinburgh)
+ 12 AuthorsEvropi Theodoratou40
Estimated H-index: 40
(Edin.: University of Edinburgh)
Background The role of urate in cardiovascular diseases (CVDs) has been extensively investigated in observational studies; however, the extent of any causal effect remains unclear, making it difficult to evaluate its clinical relevance. Methods and findings A phenome-wide association study (PheWAS) together with a Bayesian analysis of tree-structured phenotypic model (TreeWAS) was performed to examine disease outcomes related to genetically determined serum urate levels in 339,256 unrelated White British individuals (54% female) in the UK Biobank who were aged 40–69 years (mean age, 56.87; SD, 7.99) when recruited from 2006 to 2010. Mendelian randomization (MR) analyses were performed to replicate significant findings using various genome-wide association study (GWAS) consortia data. Sensitivity analyses were conducted to examine possible pleiotropic effects on metabolic traits of the genetic variants used as instruments for urate. PheWAS analysis, examining the association with 1,431 disease outcomes, identified 13 distinct phecodes representing 4 disease groups (inflammatory polyarthropathies, hypertensive disease, circulatory disease, and metabolic disorders) and 9 disease outcomes (gout, gouty arthropathy, pyogenic arthritis, essential hypertension, coronary atherosclerosis, ischemic heart disease, chronic ischemic heart disease, myocardial infarction, and hypercholesterolemia) that were associated with genetically determined serum urate levels after multiple testing correction (p < 3.35 × 10−4). TreeWAS analysis, examining 10,750 ICD-10 diagnostic terms, identified more sub-phenotypes of cardiovascular and cerebrovascular diseases (e.g., angina pectoris, heart failure, cerebral infarction). MR analysis successfully replicated the association with gout, hypertension, heart diseases, and blood lipid levels but indicated the existence of genetic pleiotropy. Sensitivity analyses support an inference that pleiotropic effects of genetic variants on urate and metabolic traits contribute to the observational associations with CVDs. The main limitations of this study relate to possible bias from pleiotropic effects of the considered genetic variants and possible misclassification of cases for mild disease that did not require hospitalization. Conclusion In this study, high serum urate levels were found to be associated with increased risk of different types of cardiac events. The finding of genetic pleiotropy indicates the existence of common upstream pathological elements influencing both urate and metabolic traits, and this may suggest new opportunities and challenges for developing drugs targeting a common mediator that would be beneficial for both the treatment of gout and the prevention of cardiovascular comorbidities.
  • References (30)
  • Citations (0)
#1Daniel M. Jordan (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 13
#2Hyon K. Choi (Harvard University)H-Index: 85
Last.Ron Do (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 39
view all 8 authors...
4 CitationsSource
#1Stephen Burgess (University of Cambridge)H-Index: 43
92 CitationsSource
#1Xue Li (Edin.: University of Edinburgh)H-Index: 8
#2Xiangrui Meng (Edin.: University of Edinburgh)H-Index: 5
Last.Evropi TheodoratouH-Index: 7
view all 16 authors...
12 CitationsSource
#1Adrian Cortes (University of Oxford)H-Index: 20
#2Calliope A. Dendrou (University of Oxford)H-Index: 15
Last.Gilean McVean (University of Oxford)H-Index: 80
view all 10 authors...
20 CitationsSource
#1Gibran Hemani (UoB: University of Bristol)H-Index: 33
#2Jack Bowden (UoB: University of Bristol)H-Index: 29
Last.George Davey-Smith (UoB: University of Bristol)H-Index: 189
view all 8 authors...
23 CitationsSource
#1Xue Li (Edin.: University of Edinburgh)H-Index: 8
#2Xiangrui Meng (Edin.: University of Edinburgh)H-Index: 5
Last.Evropi Theodoratou (Medical Research Council)H-Index: 40
view all 8 authors...
65 CitationsSource
#1Bernard Combe (University of Montpellier)H-Index: 64
#2Robert LandewéH-Index: 95
Last.Ronald F. van Vollenhoven (AMC: Academic Medical Center)H-Index: 42
view all 23 authors...
120 CitationsSource
#1Jon White (UCL: University College London)H-Index: 12
#2Reecha Sofat (UCL: University College London)H-Index: 25
Last.Aroon D. Hingorani (UCL: University College London)H-Index: 25
view all 51 authors...
52 CitationsSource
#1Marcus E. Kleber (Heidelberg University)H-Index: 51
#2Graciela Delgado (Heidelberg University)H-Index: 20
Last.Winfried März (Medical University of Graz)H-Index: 90
view all 8 authors...
74 CitationsSource
#1Claudio Borghi (UNIBO: University of Bologna)H-Index: 13
#2Enrico Agabiti-Rosei (University of Brescia)H-Index: 63
Last.Giuseppe ManciaH-Index: 128
view all 9 authors...
144 CitationsSource
Cited By0